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IN MEMORIAMIn Memoriam: Thea FriedmanOn behalf of the transplantation community, it is
with great sadness that we mark the recent passing of
Thea M. Friedman, PhD, an Associate Scientist at
the Hackensack University Medical Center, Director
of Research Laboratory Services at the John Theurer
Cancer Center, a member of the Biology of Blood and
Marrow Transplantation editorial board, and long-
term supporter of the American Society of Blood and
Marrow Transplantation. Thea contributed greatly
to our understanding of the fine specificity of the
graft-versus-host disease (GVHD) response in both
experimental allogeneic rodent bone marrow trans-
plantation (BMT) models and in the clinic. She was
a staunch advocate for women in the medical science
field, for whom she stood as a role model and a stellar
example of how one can merge a successful science
career with a fulfilling family life.
Thea received her undergraduate BS in Biology
from SUNY Albany. She undertook her graduate
training at the University of Pennsylvania with
Dr Howard Holzer, where she studied cell biology,
investigating cytoskeletal protein turnover. After re-
ceiving her PhD in 1985, Thea started her postdoc-
toral training at the Fox Chase Cancer Center,
before joining the laboratory of Dr Robert Korngold
at Jefferson Medical College in 1991. Here she began
her immersion in the field of immunology, specifically
experimental BMT. During the rest of the decade,
Thea developed a major interest in analyzing the
repertoire of T cells contributing to GVHD. She
diligently established and mastered spectratyping
methodology to enable the systematic and precise
identification of individual populations of donor
T cells after allogeneic BMT. Beginning in 1998, her
findings resulted in the publication of a series of influ-
ential papers in the Journal of Immunology and Biology ofReceived July 9, 2012; accepted July 9, 2012Blood and Marrow Transplantation reporting the identi-
fication of the major Vbeta TCR families of donor
T cells undergoing early activation in recipients devel-
oping GVHD. Importantly, she further determined
that these families differed depending on the individ-
ual transplant recipient under study.
Thea’s findings and expertise were recognized in
many venues, including included presentations at
national and international meetings and receipt of
National Institutes of Health, research foundation
and state department of health funding support, in
addition to participation as a National Institutes of
Health study section reviewer. Of her many accom-
plishments, Thea was most proud of her Amy Strelzer
Manasevit Scholar prize.This highly prestigious award,
which served as the foundation for Thea’s subsequent
R01 funding, recognized her use of TCR Vbeta spec-
tratyping to develop a new in vitro predictive assay for
GVHDinpatients and to use that information to create
novel approaches for GVHD prevention by selective
removal of the offending TCR-expressing T cells.
Thea was deeply committed to and tireless in her
mentoring of the next generation of scientists through
supervision of a wide range of trainees, from summer
interns to masters and PhD students, as well as post-
doctoral fellows.
Thea’s passion for science was not deterred by her
diagnosis of amyotrophic lateral sclerosis. Despite her
considerable challenges, she continued to be highly
engaged in robust scientific discussions with her de-
voted husband, Dr. Robert Korngold, and never
ceased in her efforts to see her research applied in the
clinic, fulfilling the goal of her Amy Strezler Manasevit
award. Her conviction in searching for new transla-
tional approaches was perhaps most evident in her par-
ticipation in the testing of new immunomodulatory
therapies to ameliorate her own disease.
Although Thea’s career was tragically curtailed, she
will be long remembered for her many scientific contri-
butions, caring and warmth for her trainees and col-
leagues, effervescent personality, and infectious laughter.
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